Microarray expression profiling of long non-coding RNAs involved in nasopharyngeal carcinoma metastasis

International Journal of Molecular Sciences

Volumn 17, Issue 11, 2016, Pages

  Wen, Xin ^a   Tang, Xinran ^a   Li, Yingqin ^a   Ren, Xianyue ^a   He, Qingmei ^a   Yang, Xiaojing ^a   Zhang, Jian ^a   Wang, Yaqin ^a   Ma, Jun ^a   Liu, Na ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Long non coding RNA; Metastasis; Microarray; Nasopharyngeal carcinoma

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; LONG UNTRANSLATED RNA; MESSENGER RNA;

ANTAGONISTS AND INHIBITORS; BIOLOGY; CARCINOGENESIS; CASE CONTROL STUDY; CELL MOTION; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LYMPH NODE METASTASIS; METABOLISM; MICROARRAY ANALYSIS; NASOPHARYNX TUMOR; PATHOLOGY; TUMOR CELL LINE;

CARCINOGENESIS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL MOVEMENT; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MICROARRAY ANALYSIS; NASOPHARYNGEAL NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGORIBONUCLEOTIDES, ANTISENSE; RNA, LONG NONCODING; RNA, MESSENGER;

EID: 84997080382     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17111956     Document Type: Article

References (45)

1. Torre, L.A.; Bray, F.; Siegel, R.L.; Ferlay, J.; Lortet-Tieulent, J.; Jemal, A. Global cancer statistics, 2012. CA Cancer J. Clin. 2015, 65, 87–108.
2. Liu, N.; Chen, N.Y.; Cui, R.X.; Li, W.F.; Li, Y.; Wei, R.R.; Zhang, M.Y.; Sun, Y.; Huang, B.J.; Chen, M.; et al. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: A microRNA expression analysis. Lancet Oncol. 2012, 13, 633–641.
3. Ng, W.T.; Choi, C.W.; Lee, M.C.; Chan, S.H.; Yau, T.K.; Lee, A.W. Familial nasopharyngeal carcinoma in hong kong: Epidemiology and implication in screening. Fam. Cancer 2009, 8, 103–108.
4. Feng, B.J.; Huang, W.; Shugart, Y.Y.; Lee, M.K.; Zhang, F.; Xia, J.C.; Wang, H.Y.; Huang, T.B.; Jian, S.W.; Huang, P.; et al. Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat. Genet. 2002, 31, 395–399.
5. Sarmiento, M.P.; Mejia, M.B. Preliminary assessment of nasopharyngeal carcinoma incidence in the philippines: A second look at published data from four centers. Chin. J. Cancer 2014, 33, 159–164.
6. Lai, S.Z.; Li, W.F.; Chen, L.; Luo, W.; Chen, Y.Y.; Liu, L.Z.; Sun, Y.; Lin, A.H.; Liu, M.Z.; Ma, J. How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int. J. Radiat. Oncol. Biol. Phys. 2011, 80, 661–668.
7. Chen, Y.; Sun, Y.; Liang, S.B.; Zong, J.F.; Li, W.F.; Chen, M.; Chen, L.; Mao, Y.P.; Tang, L.L.; Guo, Y.; et al. Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China. Cancer 2013, 119, 2230–2238.
8. Mehlen, P.; Puisieux, A. Metastasis: A question of life or death. Nat. Rev. Cancer 2006, 6, 449–458.
9. Gibb, E.A.; Brown, C.J.; Lam, W.L. The functional role of long non-coding RNA in human carcinomas. Mol. Cancer 2011, 10.
10. Hirata, H.; Hinoda, Y.; Shahryari, V.; Deng, G.; Nakajima, K.; Tabatabai, Z.L.; Ishii, N.; Dahiya, R. Long noncoding RNA MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and interacts with miR-205. Cancer Res. 2015, 75, 1322–1331.
11. Yuan, J.H.; Yang, F.; Wang, F.; Ma, J.Z.; Guo, Y.J.; Tao, Q.F.; Liu, F.; Pan, W.; Wang, T.T.; Zhou, C.C.; et al. A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 2014, 25, 666–681.
12. Xu, T.P.; Liu, X.X.; Xia, R.; Yin, L.; Kong, R.; Chen, W.M.; Huang, M.D.; Shu, Y.Q. SP1-induced upregulation of the long noncoding RNA TINCR regulates cell proliferation and apoptosis by affecting KLF2 mRNA stability in gastric cancer. Oncogene 2015, 34, 5648–5661.
13. Geisler, S.; Coller, J. RNA in unexpected places: Long non-coding RNA functions in diverse cellular contexts. Nat. Rev. Mol. Cell Biol. 2013, 14, 699–712.
14. Roberts, T.C.; Morris, K.V.; Weinberg, M.S. Perspectives on the mechanism of transcriptional regulation by long non-coding RNAs. Epigenetics 2014, 9, 13–20.
15. Wang, K.C.; Chang, H.Y. Molecular mechanisms of long noncoding RNAs. Mol. Cell 2011, 43, 904–914.
16. Lu, Y.; Li, T.; Wei, G.; Liu, L.; Chen, Q.; Xu, L.; Zhang, K.; Zeng, D.; Liao, R. The long non-coding RNA NEAT1 regulates epithelial to mesenchymal transition and radioresistance in through miR-204/ZEB1 axis in nasopharyngeal carcinoma. Tumour Biol. 2016.
17. Zhuang, K.; Wu, Q.; Jin, C.S.; Yuan, H.J.; Cheng, J.Z. Long non-coding RNA HNF1A-AS is upregulated and promotes cell proliferation and metastasis in nasopharyngeal carcinoma. Cancer Biomark. 2016, 16, 291–300.
18. Jin, C.; Yan, B.; Lu, Q.; Lin, Y.; Ma, L. The role of MALAT1/miR-1/slug axis on radioresistance in nasopharyngeal carcinoma. Tumour Biol. 2016, 37, 4025–4033.
19. Nie, Y.; Liu, X.; Qu, S.; Song, E.; Zou, H.; Gong, C. Long non-coding RNA hotair is an independent prognostic marker for nasopharyngeal carcinoma progression and survival. Cancer Sci. 2013, 104, 458–464.
20. Zhang, W.; Huang, C.; Gong, Z.; Zhao, Y.; Tang, K.; Li, X.; Fan, S.; Shi, L.; Li, X.; Zhang, P.; et al. Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma. J. Mol. Histol. 2013, 44, 545–554.
21. Tu, L.X.; Fang, W.Y.; Liu, Z.; Li, X.; He, Y.; Xie, S.M.; Yao, K.T. Establishment of a stable nasopharyngeal carcinoma cell line with lentivirus-mediated RNA interference for EIF4G1 gene silencing. Nan Fang Yi Ke Da Xue Xue Bao 2009, 29, 844–847.
22. Li, X.J.; Ong, C.K.; Cao, Y.; Xiang, Y.Q.; Shao, J.Y.; Ooi, A.; Peng, L.X.; Lu, W.H.; Zhang, Z.; Petillo, D.; et al. Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis. Cancer Res. 2011, 71, 3162–3172.
23. Li, G.P.; Wang, H.; Lai, Y.K.; Chen, S.C.; Lin, M.C.; Lu, G.; Zhang, J.F.; He, X.G.; Qian, C.N.; Kung, H.F. Proteomic profiling between CNE-2 and its strongly metastatic subclone S-18 and functional characterization of HSP27 in metastasis of nasopharyngeal carcinoma. Proteomics 2011, 11, 2911–2920.
24. Gene Ontology Consortium. Gene ontology consortium: Going forward. Nucleic Acids Res. 2015, 43, D1049–D1056.
25. Ou, S.H.; Zell, J.A.; Ziogas, A.; Anton-Culver, H. Epidemiology of nasopharyngeal carcinoma in the united states: Improved survival of chinese patients within the keratinizing squamous cell carcinoma histology. Ann. Oncol. 2007, 18, 29–35.
26. Cao, S.M.; Simons, M.J.; Qian, C.N. The prevalence and prevention of nasopharyngeal carcinoma in China. Chin. J. Cancer 2011, 30, 114–119.
27. Yang, F.; Zhang, L.; Huo, X.S.; Yuan, J.H.; Xu, D.; Yuan, S.X.; Zhu, N.; Zhou, W.P.; Yang, G.S.; Wang, Y.Z.; et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 2011, 54, 1679–1689.
28. Li, X.; Lin, Y.; Yang, X.; Wu, X.; He, X. Long noncoding RNA H19 regulates EZH2 expression by interacting with miR-630 and promotes cell invasion in nasopharyngeal carcinoma. Biochem. Biophys. Res. Commun. 2016, 473, 913–919.
29. Bo, H.; Gong, Z.; Zhang, W.; Li, X.; Zeng, Y.; Liao, Q.; Chen, P.; Shi, L.; Lian, Y.; Jing, Y.; et al. Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma. Oncotarget 2015, 6, 20404–20418.
30. Gao, W.; Chan, J.Y.; Wong, T.S. Differential expression of long noncoding RNA in primary and recurrent nasopharyngeal carcinoma. BioMed Res. Int. 2014, 2014.
31. Yang, Q.Q.; Deng, Y.F. Genome-wide analysis of long non-coding RNA in primary nasopharyngeal carcinoma by microarray. Histopathology 2015, 66, 1022–1030.
32. Zhang, B.; Wang, D.; Wu, J.; Tang, J.; Chen, W.; Chen, X.; Zhang, D.; Deng, Y.; Guo, M.; Wang, Y.; et al. Expression profiling and functional prediction of long noncoding RNAs in nasopharyngeal nonkeratinizing carcinoma. Discov. Med. 2016, 21, 239–250.
33. Liu, T.H.; Zheng, F.; Cai, M.Y.; Guo, L.; Lin, H.X.; Chen, J.W.; Liao, Y.J.; Kung, H.F.; Zeng, Y.X.; Xie, D. The putative tumor activator ARHGEF3 promotes nasopharyngeal carcinoma cell pathogenesis by inhibiting cellular apoptosis. Oncotarget 2016, 7, 225836–225848.
34. Hui, K.F.; Lam, B.H.; Ho, D.N.; Tsao, S.W.; Chiang, A.K. Bortezomib and SAHA synergistically induce ROS-driven caspase-dependent apoptosis of nasopharyngeal carcinoma and block replication of Epstein-Barr virus. Mol. Cancer Ther. 2013, 12, 747–758.
35. Lu, Z.X.; Ma, X.Q.; Yang, L.F.; Wang, Z.L.; Zeng, L.; Li, Z.J.; Li, X.N.; Tang, M.; Yi, W.; Gong, J.P.; et al. Dnazymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma. Cancer Lett. 2008, 265, 226–238.
36. Yang, C.F.; Peng, L.X.; Huang, T.J.; Yang, G.D.; Chu, Q.Q.; Liang, Y.Y.; Cao, X.; Xie, P.; Zheng, L.S.; Huang, H.B.; et al. Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway. Cancer Lett. 2014, 344, 260–271.
37. Crook, T.; Nicholls, J.M.; Brooks, L.; O’Nions, J.; Allday, M.J. High level expression of ∆N-p63: A mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)? Oncogene 2000, 19, 3439–3444.
38. Chen, C.C.; Liu, H.P.; Chao, M.; Liang, Y.; Tsang, N.M.; Huang, H.Y.; Wu, C.C.; Chang, Y.S. NF-κB-mediated transcriptional upregulation of TNFAIP2 by the Epstein-Barr virus oncoprotein, LMP1, promotes cell motility in nasopharyngeal carcinoma. Oncogene 2014, 33, 3648–3659.
39. Niemhom, S.; Kitazawa, S.; Murao, S.; Kunachak, S.; Maeda, S. Co-expression of p53 and BCL-2 may correlate to the presence of Epstein-Barr virus genome and the expression of proliferating cell nuclear antigen in nasopharyngeal carcinoma. Cancer Lett. 2000, 160, 199–208.
40. Yates, A.; Akanni, W.; Amode, M.R.; Barrell, D.; Billis, K.; Carvalho-Silva, D.; Cummins, C.; Clapham, P.; Fitzgerald, S.; Gil, L.; et al. Ensembl 2016. Nucleic Acids Res. 2016, 44, D710–D716.
41. Qi, P.; Zhou, X.Y.; Du, X. Circulating long non-coding RNAs in cancer: Current status and future perspectives. Mol. Cancer 2016, 15.
42. Dong, L.; Qi, P.; Xu, M.D.; Ni, S.J.; Huang, D.; Xu, Q.H.; Weng, W.W.; Tan, C.; Sheng, W.Q.; Zhou, X.Y.; et al. Circulating CUDR, LSINCT-5 and PTENP1 long noncoding RNAs in sera distinguish patients with gastric cancer from healthy controls. Int. J. Cancer 2015, 137, 1128–1135.
43. Su, Y.J.; Yu, J.; Huang, Y.Q.; Yang, J. Circulating long noncoding RNA as a potential target for prostate cancer. Int. J. Mol. Sci. 2015, 16, 13322–13338.
44. Fayda, M.; Isin, M.; Tambas, M.; Guveli, M.; Meral, R.; Altun, M.; Sahin, D.; Ozkan, G.; Sanli, Y.; Isin, H.; et al. Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy? Tumour Biol. 2016, 37, 3969–3978.
45. −∆∆Ct method. Methods 2001, 25, 402–408.